Sreekanth R Kancharla

Sreekanth R Kancharla has over two decades of experience in the healthcare and pharmaceutical industries, currently serving as a Director in R&D IS at Amgen since June 2004, where Sreekanth leads the implementation of the TransCelerate Shared Investigator Platform. Prior roles include Senior Manager in R&D IS at Amgen, Clinical Applications Administrator at Lilly Venture (i3 Statprobe), Oracle Clinical Developer at Pfizer, and Business Analyst at Superior Consultants. Sreekanth also contributed as a Research Associate in Gene Therapy at the University of Alabama at Birmingham, developing adenoviral vectors for cancer treatment. Educational qualifications include a Master's in Health Informatics from the University of Alabama at Birmingham, a Master's in Molecular Virology from Mississippi State University, and a Master of Veterinary Science from SV Veterinary University in India.